Viewing Study NCT02389751


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-02-25 @ 9:49 PM
Study NCT ID: NCT02389751
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2015-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2013-0815
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View